Viewing Study NCT02206295

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 1:36 PM

Ignite Modification Date: 2026-04-13 @ 10:16 PM

Study NCT ID: NCT02206295

Status: COMPLETED

Last Update Posted: 2025-02-03

First Post: 2014-07-30

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg

Sponsor: Actelion

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module